Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.
<h4>Background</h4>Immune biomarkers are implicated in HCV treatment response, fibrosis, and accelerated pathogenesis of comorbidities, though only D-dimer and C-reactive protein have been consistently studied. Few studies have evaluated HIV/HCV co-infection, and little longitudinal data...
Saved in:
| Main Authors: | Lauren E Kushner, Aaron M Wendelboe, Laura C Lazzeroni, Aarthi Chary, Mark A Winters, Anu Osinusi, Shyam Kottilil, Michael A Polis, Mark Holodniy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0060387&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Threshold value of the anti-HCV test in the diagnosis of HCV infection
by: Özlem Kirişci, et al.
Published: (2019-10-01) -
HCV and HBV genotypes: vital in the progression of HCV/ HBV co-infection
by: Yasmin Badshah, et al.
Published: (2025-01-01) -
Treatment of HCV Infection in Children
by: Ruggiero Francavilla, et al.
Published: (2000-01-01) -
Analysis of mortality and risk of death in HCV- and HCV/HIV-infected patients with extrahepatic manifestations
by: N. V. Dunaeva, et al.
Published: (2022-07-01) -
Glances in Immunology of HIV and HCV Infection
by: Maria Giovanna Quaranta, et al.
Published: (2012-01-01)